Log in to save to my catalogue

Bleomycin-Induced Flagellate Dermatitis

Bleomycin-Induced Flagellate Dermatitis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_870c9930305c4fad983cace4fc36059f

Bleomycin-Induced Flagellate Dermatitis

About this item

Full title

Bleomycin-Induced Flagellate Dermatitis

Publisher

Turkey: Türk Hematoloji Derneği

Journal title

Turkish journal of haematology, 2019-05, Vol.36 (2), p.138-140

Language

English

Formats

Publication information

Publisher

Turkey: Türk Hematoloji Derneği

More information

Scope and Contents

Contents

Bleomycin is a cytostatic, antineoplastic antibiotic that is used
in both of the first-line treatments of Hodgkin lymphoma:
ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine)
and BEACOPP (doxorubicin, bleomycin, vincristine,
cyclophosphamide, etoposide, prednisone, procarbazine). The
bleomycin hydrolase enzyme metabolizes bleomy...

Alternative Titles

Full title

Bleomycin-Induced Flagellate Dermatitis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_870c9930305c4fad983cace4fc36059f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_870c9930305c4fad983cace4fc36059f

Other Identifiers

ISSN

1300-7777

E-ISSN

1308-5263

DOI

10.4274/tjh.galenos.2019.2018.0317

How to access this item